Crescent Biopharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Crescent Biopharma Inc
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
/ 
Frequently asked questions
To buy Crescent Biopharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Crescent Biopharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Crescent Biopharma Inc is CBIO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Crescent Biopharma Inc has its primary listing on NASDAQ. You can trade Crescent Biopharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Crescent Biopharma Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Crescent Biopharma Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Crescent Biopharma Inc.